These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28601374)

  • 21. Differential Effect of Iron and Myelin on Susceptibility MRI in the Substantia Nigra.
    Lee H; Cho H; Lee MJ; Kim TH; Roh J; Lee JH
    Radiology; 2021 Dec; 301(3):682-691. PubMed ID: 34609198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative Susceptibility Mapping in Parkinson's Disease.
    Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
    PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative susceptibility mapping across two clinical field strengths: Contrast-to-noise ratio enhancement at 1.5T.
    Ippoliti M; Adams LC; Winfried B; Hamm B; Spincemaille P; Wang Y; Makowski MR
    J Magn Reson Imaging; 2018 Nov; 48(5):1410-1420. PubMed ID: 29659131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of respiratory hyperoxic challenge on magnetic susceptibility in human brain assessed by quantitative susceptibility mapping (QSM).
    Özbay PS; Rossi C; Kocian R; Redle M; Boss A; Pruessmann KP; Nanz D
    NMR Biomed; 2015 Dec; 28(12):1688-96. PubMed ID: 26484968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. R2* and quantitative susceptibility mapping in deep gray matter of 498 healthy controls from 5 to 90 years.
    Treit S; Naji N; Seres P; Rickard J; Stolz E; Wilman AH; Beaulieu C
    Hum Brain Mapp; 2021 Oct; 42(14):4597-4610. PubMed ID: 34184808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of deep grey nuclei susceptibility in early childhood: a quantitative susceptibility mapping and R2* study at 3 Tesla.
    Raab P; Ropele S; Bültmann E; Salcher R; Lanfermann H; Wattjes MP
    Neuroradiology; 2022 May; 64(5):1021-1031. PubMed ID: 34787698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantifying Brain Iron in Hereditary Hemochromatosis Using R2* and Susceptibility Mapping.
    Sethi SK; Sharma S; Gharabaghi S; Reese D; Chen Y; Adams P; Jog MS; Haacke EM
    AJNR Am J Neuroradiol; 2022 Jul; 43(7):991-997. PubMed ID: 35798390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of mesoscopic properties of deep gray matter iron through a model-based simultaneous analysis of magnetic susceptibility and R
    Taege Y; Hagemeier J; Bergsland N; Dwyer MG; Weinstock-Guttman B; Zivadinov R; Schweser F
    Neuroimage; 2019 Feb; 186():308-320. PubMed ID: 30445148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of extended spatial coverage for quantitative susceptibility mapping of iron-rich deep gray matter.
    Elkady AM; Sun H; Wilman AH
    Magn Reson Imaging; 2016 May; 34(4):574-8. PubMed ID: 26721523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The choice of embedding media affects image quality, tissue R
    Dusek P; Madai VI; Huelnhagen T; Bahn E; Matej R; Sobesky J; Niendorf T; Acosta-Cabronero J; Wuerfel J
    Magn Reson Med; 2019 Apr; 81(4):2688-2701. PubMed ID: 30506939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping.
    Chen Y; Liu S; Wang Y; Kang Y; Haacke EM
    Magn Reson Imaging; 2018 Feb; 46():130-139. PubMed ID: 29056394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping.
    Liu M; Liu S; Ghassaban K; Zheng W; Dicicco D; Miao Y; Habib C; Jazmati T; Haacke EM
    J Magn Reson Imaging; 2016 Jul; 44(1):59-71. PubMed ID: 26695834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible, irreversible and effective transverse relaxation rates in normal aging brain at 3T.
    Sedlacik J; Boelmans K; Löbel U; Holst B; Siemonsen S; Fiehler J
    Neuroimage; 2014 Jan; 84():1032-41. PubMed ID: 24004692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative susceptibility mapping of the rat brain after traumatic brain injury.
    Chary K; Nissi MJ; Nykänen O; Manninen E; Rey RI; Shmueli K; Sierra A; Gröhn O
    NMR Biomed; 2021 Feb; 34(2):e4438. PubMed ID: 33219598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishing intra- and inter-vendor reproducibility of T
    Lee Y; Callaghan MF; Acosta-Cabronero J; Lutti A; Nagy Z
    Magn Reson Med; 2019 Jan; 81(1):454-465. PubMed ID: 30159953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unraveling Deep Gray Matter Atrophy and Iron and Myelin Changes in Multiple Sclerosis.
    Pontillo G; Petracca M; Monti S; Quarantelli M; Criscuolo C; Lanzillo R; Tedeschi E; Elefante A; Brescia Morra V; Brunetti A; Cocozza S; Palma G
    AJNR Am J Neuroradiol; 2021 Jul; 42(7):1223-1230. PubMed ID: 33888456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative susceptibility mapping-based cerebral metabolic rate of oxygen mapping with minimum local variance.
    Zhang J; Cho J; Zhou D; Nguyen TD; Spincemaille P; Gupta A; Wang Y
    Magn Reson Med; 2018 Jan; 79(1):172-179. PubMed ID: 28295523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study.
    Langkammer C; Schweser F; Krebs N; Deistung A; Goessler W; Scheurer E; Sommer K; Reishofer G; Yen K; Fazekas F; Ropele S; Reichenbach JR
    Neuroimage; 2012 Sep; 62(3):1593-9. PubMed ID: 22634862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength.
    Deistung A; Schäfer A; Schweser F; Biedermann U; Turner R; Reichenbach JR
    Neuroimage; 2013 Jan; 65():299-314. PubMed ID: 23036448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Voxel-Based Intraclass Correlation Coefficient to Evaluate the Inter- Scanner Reproducibility of Quantitative Susceptibility Mapping Over the Deep Gray Matter Structure at 3.0T MR.
    Meng Q; Liu M; Chen Z
    Curr Med Imaging; 2022; 18(9):924-930. PubMed ID: 35170418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.